APA

Taylor J. W., Dietrich J., Gerstner E. R., Norden A. D., Rinne M. L., Cahill D. P., Stemmer-Rachamimov A., Wen P. Y., Betensky R. A., Giorgio D. H., Snodgrass K., Randall A. E., Batchelor T. T. & Chi A. S. (20151027). Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma. : Journal of neuro-oncology.

Chicago

Taylor Jennie W, Dietrich Jorg, Gerstner Elizabeth R, Norden Andrew D, Rinne Mikael L, Cahill Daniel P, Stemmer-Rachamimov Anat, Wen Patrick Y, Betensky Rebecca A, Giorgio Diana H, Snodgrass Kellis, Randall Alison E, Batchelor Tracy T and Chi Andrew S. 20151027. Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma. : Journal of neuro-oncology.

Harvard

Taylor J. W., Dietrich J., Gerstner E. R., Norden A. D., Rinne M. L., Cahill D. P., Stemmer-Rachamimov A., Wen P. Y., Betensky R. A., Giorgio D. H., Snodgrass K., Randall A. E., Batchelor T. T. and Chi A. S. (20151027). Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma. : Journal of neuro-oncology.

MLA

Taylor Jennie W, Dietrich Jorg, Gerstner Elizabeth R, Norden Andrew D, Rinne Mikael L, Cahill Daniel P, Stemmer-Rachamimov Anat, Wen Patrick Y, Betensky Rebecca A, Giorgio Diana H, Snodgrass Kellis, Randall Alison E, Batchelor Tracy T and Chi Andrew S. Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma. : Journal of neuro-oncology. 20151027.